pharmaphorum December 6, 2022

Clinical trials are the engine for pharmaceutical innovation, but their means of capturing and communicating data are stuck in the past. Recognising an opportunity to develop better tools for clinical trial leaders to share and stream data, YonaLink’s co-founders built a software solution that addresses the interoperability gap in clinical trial operations. Iddo Peleg (CEO, and one of the four co-founders of YonaLink) and Gav Martell (co-founder and vice president of business development) discussed how a recent $6 million funding round led by Debiopharm Innovation Fund will support their mission to transform clinical trials and bring lifesaving therapies to market faster.

While many pieces of the drug development process have digitised to keep pace with the speed of technological advancements,...

Today's Sponsors


Today's Sponsor

Health Edge

Topics: Biotechnology, Clinical Trials, EMR / EHR, Health IT, HIE (Interoperability), Investments, Pharma, Pharma / Biotech, Technology, Trends
Three Wild Health Technologies in (or Close to) Clinical Trials
How the Cloud Can Improve Data Sets for Real-World Evidence in Clinical Trials
Health Equity Barriers in Oncology Trials
Nationwide Children's Hospital AI spinoff acquired by new $200M clinical trial startup
Clinical trial company Science 37 buys life science assets from Vault Health

Share This Article